Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
171.7 USD | +3.51% | -5.22% | -20.88% |
Mar. 08 | 3M Board Approves Healthcare Unit Spinoff -- Update | DJ |
Mar. 08 | Transcript : Insulet Corporation - Special Call |
Business Summary
- Insulin pump therapy systems (95.6%): continuous insulin management and delivery systems (Omnipod® and Omnipod DASH® brands) and automated insulin administration systems (Omnipod® 5 brand);
- non-insulin drug administration systems (4.4%): in particular pre-filled syringes for the Neulasta® Onpro® kit (intended for the treatment of neutropenia in patients treated with chemotherapy).
By the end of 2022, the group will have 2 production sites located in the United States and in China.
The United States accounts for 72.2% of net sales.
Number of employees: 3,000
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States Omnipod
73.7
%
| 885 | 67.8 % | 1,251 | 73.7 % | +41.39% |
International Omnipod
24.2
%
| 363 | 27.8 % | 410 | 24.2 % | +12.98% |
Drug Delivery
2.1
%
| 58 | 4.4 % | 36 | 2.1 % | -37.39% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
75.8
%
| 942 | 72.2 % | 1,287 | 75.8 % | +36.58% |
International
24.2
%
| 363 | 27.8 % | 410 | 24.2 % | +12.98% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 19-07-30 | |
Deborah Gordon
FOU | Founder | 54 | 13-12-31 |
Lauren Budden
DFI | Director of Finance/CFO | 49 | 19-04-28 |
Mark Field
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Prem Singh
COO | Chief Operating Officer | 47 | - |
Trang Ly
CTO | Chief Tech/Sci/R&D Officer | - | 16-09-11 |
Shacey Petrovic
BRD | Director/Board Member | 51 | 15-02-09 |
Patrick Crannell
PRN | Corporate Officer/Principal | - | - |
Dan Manea
HRO | Human Resources Officer | 57 | 20-04-30 |
Eric Benjamin
PRN | Corporate Officer/Principal | 41 | 18-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Minogue
BRD | Director/Board Member | 57 | 17-08-09 |
Timothy Scannell
CHM | Chairman | 60 | 14-08-13 |
Director/Board Member | 64 | 22-02-03 | |
Corinne Nevinny
BRD | Director/Board Member | 64 | 19-01-27 |
Chief Executive Officer | 61 | 19-07-30 | |
Wayne Frederick
BRD | Director/Board Member | 52 | 20-10-19 |
Shacey Petrovic
BRD | Director/Board Member | 51 | 15-02-09 |
Jessica Hopfield
BRD | Director/Board Member | 59 | 15-07-26 |
Luciana Borio
BRD | Director/Board Member | 53 | 21-10-17 |
Flavia Pease
BRD | Director/Board Member | 51 | Jan. 17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,925,730 | 69,532,792 ( 99.44 %) | 0 | 99.44 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.88% | 11.6B | |
+2.15% | 200B | |
+1.55% | 111B | |
-2.51% | 68.39B | |
+8.57% | 50.29B | |
+16.52% | 47.47B | |
+8.79% | 45.04B | |
+10.61% | 28.87B | |
+7.68% | 28.45B | |
+12.38% | 28.38B |
- Stock
- Equities
- Stock Insulet Corporation - Nasdaq
- Company Insulet Corporation